Literature DB >> 29274804

A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin.

Ahmet Cagdas Acara1, Mustafa Bolatkale2, İlker Kızıloğlu3, Ersin İbişoğlu4, Çağdaş Can5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29274804     DOI： 10.1016/j.ajem.2017.12.032

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  8 in total

Review 1.  Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease.

Authors:  Mehmet Akif Ovali; Ibrahim Bozgeyik
Journal:  Mol Syndromol       Date:  2022-02-08

2.  Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study.

Authors:  Nariman Moradi; Fatima Zahraa Fouani; Akram Vatannejad; Abbas Bakhti Arani; Soraya Shahrzad; Reza Fadaei
Journal:  Lipids Health Dis       Date:  2021-08-21       Impact factor: 3.876

Review 3.  Energy Regulation Mechanism and Therapeutic Potential of Asprosin.

Authors:  Jennifer G Hoffmann; Wei Xie; Atul R Chopra
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

Review 4.  A state of the art review on the novel mediator asprosin in the metabolic syndrome.

Authors:  Carla Luís; Rúben Fernandes; Raquel Soares; Pedro von Hafe
Journal:  Porto Biomed J       Date:  2020-12-10

5.  Increased serum asprosin is correlated with diabetic nephropathy.

Authors:  Rui Wang; Peng Lin; Huibo Sun; Wenchao Hu
Journal:  Diabetol Metab Syndr       Date:  2021-05-01       Impact factor: 5.395

6.  Evaluation of Plasma Asprosin Concentration in Patients with Coronary Artery Disease.

Authors:  Cengiz Güven; Hüseyin Kafadar
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16

Review 7.  Asprosin: A Novel Player in Metabolic Diseases.

Authors:  Mingyang Yuan; Weidong Li; Yan Zhu; Boyao Yu; Jing Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-19       Impact factor: 5.555

8.  Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus.

Authors:  Xinyue Zhang; Hui Jiang; Xiaojing Ma; Hongyan Wu
Journal:  J Diabetes Investig       Date:  2019-10-03       Impact factor: 4.232
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.